Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 4 de 4
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
Vasa ; 50(4): 250-264, 2021 Jul.
Artigo em Inglês | MEDLINE | ID: mdl-33459041

RESUMO

Inferior vena cava syndrome (IVCS) is caused by agenesis, compression, invasion, or thrombosis of the IVC, or may be associated with Budd-Chiari syndrome. Its incidence and prevalence are unknown. Benign IVCS is separated from malignant IVCS. Both cover a wide clinical spectrum reaching from asymptomatic to highly symptomatic cases correlated to the underlying cause, the acuity, the extent of the venous obstruction, and the recruitment and development of venous collateral circuits. Imaging is necessary to determine the underlying cause of IVCS and to guide clinical decisions. Interventional therapy has changed the therapeutic approach in symptomatic patients. This article provides an overview over IVCS and focuses on interventional therapeutic methods and results.


Assuntos
Síndrome de Budd-Chiari , Trombose , Humanos , Veia Cava Inferior
2.
Vasa ; 49(6): 437-448, 2020 Oct.
Artigo em Inglês | MEDLINE | ID: mdl-33103626

RESUMO

The superior vena cava syndrome (SVCS) is caused by compression, invasion, and/or thrombosis of the superior vena cava and/or the brachiocephalic veins. Benign SVCS is separated from malignant SVCS. SVCS comprises a broad clinical spectrum reaching from asymptomatic cases to rare life-threatening emergencies with upper airway obstruction and increased intracranial pressure. Symptoms are correlated to the acuity and extent of the venous obstruction and inversely correlated to the development of the venous collateral circuits. Imaging is necessary to determine the exact underlying cause and to guide further interventions. Interventional therapy has widely changed the therapeutic approach in symptomatic patients. This article provides an overview over this complex syndrome and focuses on interventional therapeutic methods and results.


Assuntos
Síndrome da Veia Cava Superior , Veias Braquiocefálicas , Humanos , Stents , Síndrome da Veia Cava Superior/diagnóstico por imagem , Síndrome da Veia Cava Superior/etiologia , Veia Cava Superior
3.
Vasa ; 47(2): 91-97, 2018 Feb.
Artigo em Inglês | MEDLINE | ID: mdl-29299961

RESUMO

Erythromelalgia is a rare syndrome characterized by the intermittent or, less commonly, by the permanent occurrence of extremely painful hyperperfused skin areas mainly located in the distal extremities. Primary erythromelalgia is nowadays considered to be a genetically determined neuropathic disorder affecting SCN9A, SCN10A, and SCN11A coding for NaV1.7, NaV1.8, and NaV1.9 neuronal sodium channels. Secondary forms might be associated with myeloproliferative disorders, connective tissue disease, cancer, infections, and poisoning. Between the pain episodes, the affected skin areas are usually asymptomatic, but there are patients with typical features of acrocyanosis and/or Raynaud's phenomenon preceding or occurring in between the episodes of erythromelalgia. Diagnosis is made by ascertaining the typical clinical features. Thereafter, the differentiation between primary and secondary forms should be made. Genetic testing is recommended, especially in premature cases and in cases of family clustering in specialized genetic institutions after genetic counselling. Multimodal therapeutic intervention aims toward attenuation of pain and improvement of the patient's quality of life. For this purpose, a wide variety of nonpharmacological approaches and pharmacological substances for topical and systemic use have been proposed, which are usually applied individually in a step-by-step approach. Prognosis mainly depends on the underlying condition and the ability of the patients and their relatives to cope with the disease.


Assuntos
Eritromelalgia , Eritromelalgia/diagnóstico , Eritromelalgia/epidemiologia , Eritromelalgia/genética , Eritromelalgia/terapia , Predisposição Genética para Doença , Humanos , Técnicas de Diagnóstico Molecular , Medição da Dor , Fenótipo , Valor Preditivo dos Testes , Fatores de Risco , Resultado do Tratamento
4.
Vasa ; 45(5): 353-64, 2016 Sep.
Artigo em Inglês | MEDLINE | ID: mdl-27594391

RESUMO

Nailfold capillaroscopy is a method of great diagnostic value in the differential diagnosis of primary versus secondary Raynaud´s phenomenon, of systemic sclerosis versus other so called connective tissue diseases and of additional diagnostic value in other entities. Rheumatologists, dermatologists, and angiologists in Germany have convened in an interdisciplinary working group in which they synergistically combined their expertise to develop a common nomenclature and standards for the technical performance of nailfold capillary microscopy. The article gives an overview of historical and technical aspects of capillaroscopy, morphologic findings, and disease-specific patterns. It also provides a critical appraisal of its significance in the diagnosis and sequelae of these interdisciplinarily-managed diseases including its performance in children and gives an excursion in the potential perspectives of capillaroscopy in less common indications.


Assuntos
Doenças do Tecido Conjuntivo/diagnóstico , Angioscopia Microscópica , Unhas/irrigação sanguínea , Doença de Raynaud/diagnóstico , Doenças do Tecido Conjuntivo/epidemiologia , Doenças do Tecido Conjuntivo/fisiopatologia , Doenças do Tecido Conjuntivo/terapia , Diagnóstico Diferencial , Humanos , Comunicação Interdisciplinar , Valor Preditivo dos Testes , Prognóstico , Doença de Raynaud/epidemiologia , Doença de Raynaud/fisiopatologia , Doença de Raynaud/terapia
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...